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ABSTRACT 
Introduction: The objective of the work was to evaluate the effectiveness of surgical treatment 
in patients with a high risk of hypercalcaemic crisis due to primary hyperparathyroidism 
(PHPT) and to determine the best time to undergo surgery. 
Material and methods and Results: Between 2010 and 2019, 627 patients underwent surgery 
due to PHPT. Sixty-two patients (9.9%) (47 women and 15 men, aged 28–79 years, average 
53.7 years) faced the threat of a parathyroid crisis. In these patients, the average parathyroid 
hormone (PTH) levels were 774.02 pg/mL (95% CI: 203–1246 pg/mL) and ionised calcium 
(iCa2+) 1.91 mmol/L (95% CI: 1.70–2.2 mmol/L). The PTH postoperative concentration 
averaged at 37.86 pg/mL (95% CI: 9.91–42.7 pg/mL) and iCa2 + 1.11 mmol/L (95% CI: 1.07–
1.21 mmol/L). Bilateral neck exploration was performed in all patients with the removal of the 
affected parathyroid gland and biopsies of other parts. Histopathological examination revealed 
adenoma in 42 cases (67.7%), hyperplasia in 16 (25.7%), and parathyroid cancer in four of the 
patients (6.6%). Comparison of tests before and after surgery showed a statistically significant 
decrease in PTH (p < 0.001) and iCa (p < 0.001) in blood serum. 
Conclusions: A developing hypercalcaemic crisis in the course of hyperparathyroidism is an 
indication for preoperative intensive medical therapy, along with urgent surgical intervention 
and removal of diseased parathyroid glands. 
This type of surgery should be performed as soon as possible, even if there are no imaging tests, 
only based on an assessment of the general condition of the patient and their serum calcium 
levels. 
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Introduction 
Hypercalcaemic crisis is a life-threatening condition resulting from metabolic disorders 
related to excessive calcium levels in the blood serum [1–3]. This condition affects the function 
of many organs and systems, including kidneys, as well as central nervous, circulatory, and 
digestive systems. The main symptoms of a developing hypercalcaemic crisis include 
progressive polydipsia, polyuria, progressive signs of dehydration with confusion and anxiety, 
and excessive sleepiness and coma [4–6]. The exacerbation of bone pains as well as 
gastrointestinal complaints in the form of a peptic ulcer disease or pancreatitis, cardiac 
arrhythmia, or other cardiac problems are observed [7–9]. In the vast majority of cases 
(approximately 90%), hypercalcaemia occurs during PHPT and cancer, often accompanied by 
dehydration. An excessive supply of calcium, the use of certain medications (vitamin A and D 
supplements, thiazides, oestrogens, or lithium salts), and some medical conditions (kidney 
damage, thyrotoxicosis, adrenal insufficiency, pheochromocytoma, or familial hypercalciuria) 
rarely result in hypercalcaemia [5, 10]. 
The treatment of hypercalcaemic crisis is difficult and complex, and the key to success 
is the elimination of the factor leading to its occurrence as soon as possible, including early 
diagnosis and surgical treatment of PHPT. 
 
Objective of the work 
The goal of the study was to evaluate the effectiveness of surgical treatment in patients 
at risk of hypercalcaemic crisis in PHPT and to establish the best time to undergo surgery. 
 
Material and methods  
Between 2010 and 2019, 627 patients underwent surgery due to PHPT. Of this group, 
62 patients (9.9%) were admitted as a matter of urgency due to symptoms related to developing 
parathyroid crisis. In all these patients, despite previous pharmacological treatment (fluid 
therapy, diuretics, and bisphosphonates), the concentration of ionised calcium in blood serum 
exceeded 1.7 mmol/L. In addition to Ca2 +, serum PTH and creatinine levels were determined 
on ingestion, and the glomerular filtration rate (GFR) was calculated. The group consisted of 
47 women (75.8%) and 15 men (24.2%) aged 28–79 years, average 53.7 years. The location of 
the changed parathyroid glands in 56 (90.3%) patients was based on urgent MIBI–SPECT 
scintigraphy or preoperative ultrasound. In the majority of patients, parathyroid scintigraphy 
was performed electively in the course of the disease, while in the remaining six patients (9.7%) 
the clinical picture indicated the need for surgical intervention based on ionised calcium and 
PTH tests in blood serum and ultrasound imaging tests of the neck. All patients had a daily 
diuresis card and water balances.  
Bilateral neck exploration was performed in all of the patients under tracheal general 
anaesthesia, identifying all parathyroid glands. The effectiveness of surgical treatment was 
confirmed by intraoperative assessment of PTH concentration in peripheral blood serum 20 
minutes after parathyroidectomy (PTX). A statistical analysis was performed based on the 
Statistica 13.1 program with the calculation of arithmetic means, standard deviation, application 
of the Wilcoxon test, and a statistical significance assessment. 
 
Results 
In the group of 62 patients with a threatening parathyroid crisis, the average preoperative 
serum PTH level was 774.02 (95% CI: 203–1246 pg/mL) and the average concentration Ca2 + 
1.91 (95% CI: 1.70–2.20 mmol/L) (Tab. 1).  
Table 2 shows a comparison of clinical symptoms and additional diseases in the group 
of patients treated for PHPT, including those with a threatening hypercalcaemic crisis. The 
occurrence of urolithiasis, chronic renal failure, instances of consciousness or drowsiness, as 
well as acute pancreatitis in patients with threatening hypercalcaemic crisis should be 
emphasised. In all patients, after the introduction of intensive combined fluid therapy (2500–
3000 mL 0.9% NaCl) with the supply of furosemide along with potassium infusions, the 
symptoms stabilised with an increase in serum Ca2 + concentration and correction of electrolyte 
deficiencies.  
The patients were operated by classical method with bilateral neck exploration. Total 
removal of the diseased parathyroid with biopsy of the remaining glands was performed in all 
62 patients. Eleven patients (17.7%) also required a partial thyroid resection. Histopathological 
examination revealed 42 cases of adenoma (67.7%), 16 of parathyroid hyperplasia (25.7%), and 
cancer in 6.6% of patients. The size of the diseased parathyroid glands ranged from 20 to 51 
mm, 35 mm on average.  
Post-operative examination of PTH in blood serum after resection of the diseased 
parathyroid glands compared to preoperative tests showed a statistically significant decrease (p 
< 0.001) in its values — average 37.86 (CI: 9.91–42.7) pg/mL (Fig. 1). Also, the serum Ca2 + 
concentration showed a statistically significant decrease (p < 0.001) to mean values of 1.11 
(95% CI: 1.07–1.21) mmol/L (Fig. 2). Intravenous calcium infusions were used in patients in 
the early postoperative course, gradually replacing them with oral substitution in combination 
with Vit D3 analogues. The treatment was carried out under water balance control with diuresis 
control, liquid therapy, and electrolyte equalisation.  
In one patient after primary surgery for benign adenoma, signs of recurrent 
hyperparathyroidism were discovered. This patient required re-surgery combined with 
resection of the next parathyroid lesion with complete thyroidectomy. Histopathological 
examination revealed parathyroid carcinoma infiltrating the thyroid lobe. After two years, the 
patient was operated again due to the recurrence of hyperparathyroidism, recognising 
parathyroid cancer with dissemination to the surrounding tissues of the neck and mediastinum, 
and then undergoing additional radiation therapy. She is alive under oncological supervision. 
 
Discussion 
The clinical picture of PHPT is varied. In the foreground are complaints related to 
kidneys, as well as the urinary and skeletal systems. The disease is also manifested by 
gastrointestinal, cardiovascular, and nervous disorders [7, 8, 11–13]. The incidence and severity 
of individual ailments can vary and depends on serum calcium levels, critically increasing at 
levels exceeding 3.5 mmol/L [4, 10] when the first symptoms of hypercalcaemic crisis manifest 
themselves. It is believed that the concentration of ionised calcium in blood serum is 
increasingly a leading criterion for hyper- and hypocalcaemia. Values above 1.7 mmol/L 
indicate a real threat of hypercalcaemic crisis.  
According to literature data, the occurrence of hypercalcaemic crisis in the course of 
hyperparathyroidism relates to about 1.6–6% of patients [10]. Our own observations show a 
slightly higher percentage of patients at risk of its occurrence. The emerging metabolic 
disorders resulting from dyselectrolitaemia, manifested at particularly high calcium levels, 
accompanied by hypertonic dehydration leading to prerenal renal failure and features of 
metabolic acidosis, mean that hypercalcaemic crisis should be treated as a life-threatening 
condition. As shown by our own observations, most of them adapt to existing electrolyte 
disturbances due to long-term progress of the disease. Rapidly growing hypercalcaemia, which 
leads to rapid body decompensation, is extremely dangerous [4, 5, 13]. In addition to the 
initially occurring polyuria and vomiting and in the final stage of oliguria, there is, among heart 
rhythm disorders combined with bradycardia, a significant increase in body temperature and 
often the features of acute pancreatitis, to symptoms of shock manifesting as multi-organ 
failure, consciousness disorders, and coma [8, 13, 14]. Ultimately, this can lead to the death of 
the patient. 
The dramaturgy of symptoms and the turbulent clinical course make it extremely 
important to prevent the development of hypercalcaemic crisis in the course of 
hyperparathyroidism and lowering serum calcium [14, 15, 21]. These activities should include 
the preparation of the patient for surgery as soon as possible, with the aim of removing the 
diseased parathyroid gland as a factor generating hypercalcaemia and the sequence of metabolic 
disorders resulting from it [16]. A proper preparation of the patient for surgery, safety of 
anaesthesia, and the effectiveness of the surgical treatment often require interdisciplinary 
cooperation and combined efforts of an internist, nephrologist, endocrinologist, 
anaesthesiologist, and surgeon [5, 6, 15, 17, 18]. A clinical analysis of our patients indicates 
that it is not always possible to perform a MIBI parathyroid scintigraphy test, either because of 
the lack of technical capabilities or, above all, the rapidly worsening condition of the patient 
with a systematically increasing serum iCa2 + concentration. This concerned six patients 
(9.7%) operated on by us. 
Preoperative pharmacological treatment in patients with severe hypercalcaemia initially 
includes intensive hydration using isotonic sodium chloride solution [10, 22]. After the 
correction of fluid deficiencies, the treatment is continued in combination with loop diuretics 
and simultaneous correction of potassium and magnesium deficiencies. Our experience shows 
that this often effectively reduces calcium levels in the patient’s blood serum and prevents their 
further increase. It also allows the avoidance of emergency surgery and instead an urgent 
elective procedure, which, in the absence of previous diagnostic and localisation tests, also 
gives time to perform them and increases the effectiveness of the surgical treatment. This is all 
the more important because, as a rule, the patient's serious condition and the resulting loads 
representing a high risk of perioperative complications, including death, require that the surgical 
treatment be effective [6, 10, 11]. According to our own observations, giant parathyroid 
adenomas are a common cause of critically high hypercalcaemia, which is a threat of 
breakthrough, although the literature data do not indicate a simple relationship between the size 
and activity of the diseased parathyroid glands. Additionally, the possibility of a malignant 
tumour originating from parathyroid glands should always be considered [19, 21, 22]. The 
presence of goitre and the occurrence of nodular changes in the thyroid gland may significantly 
impede the identification of both pre- and intraoperative diseased parathyroid glands [20]. It 
requires simultaneous thyroid resection, which took place in 11 of our patients (17.7%), 
including unilateral “en block” lobectomy with suspected neoplastic changes. The effectiveness 
of surgical treatment should be confirmed by intraoperative PTH determination after resection 
of the affected parathyroid gland. The usefulness of these determinations was observed in the 
above-mentioned patients. 
Both our own observations and the experience of other authors point to the effectiveness 
of surgery in the treatment of hypercalcaemia, which is a pre-breakthrough state, and a rapid 
post-operative improvement in the general condition of patients [2, 6, 16–18]. Continuous 
monitoring of patients plays an extremely important role in postoperative management. 
 
Conclusions 
A developing hypercalcaemic crisis in the course of hyperparathyroidism is an indication for 
preoperative intensive medical therapy, as well as urgent surgical intervention and removal of 
diseased parathyroid glands. 
This type of surgery should be performed as soon as possible, even if there are no imaging tests, 
based only on an assessment of the general condition of the patient and their serum calcium 
levels. 
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Table 1. Threat of hypercalcaemic crisis in 62 patients operated on in 2010–2019 due to various 
forms of hyperparathyroidism  
Group of patients at risk of hypercalcaemic crisis 
Age [years] 28–79 (53.7) 
Gender (n) 
 
M 15 (24,2%) 
F 47 (75,8%) 
Cause of PHPT (n) 
 
 
Adenoma 42 (67,7%) 
Hyperplasia 16 (25,7%) 
Carcinoma 4 (6,6%) 
Size of parathyroid gland [mm] 20–51 (35)  
PTH [pg/mL] 
 
Before operation 203–1246 (774.02) 
After operation 9.91–42.7 (37.89) 
iCa2+ [mmol/L] 
 Before operation 1.7–2.2 (1.91) 
After operation 1,07–1,21 (1.11) 
PHPT — primary hyperparathyroidism; PTH — parathyroid hormone; iCA2+ — ionised 
calcium 
Table 2. Comparison of clinical symptoms in a group of 627 patients operated on due to primary 
hyperparathyroidism (PHPT) in 2010–2019 without and with a threat of hypercalcaemic crisis 
Clinical symptoms 
PHPT without threat 
of hypercalcaemic 
crisis 
(n = 565) 
PHPT with threat of 
hypercalcaemic 
crisis 
(n = 62) 
Statistical variability 
p 
Musculoskeletal pain 443 (78.4%) 30 (62.9%) 0.12 
Hypertension 273 (48.5%) 16 (25.8%) 0.104 
Kidney stones 213 (37.9%) 38 (61.2%) 0.002 
Chronic renal failure 80 (14.3%) 26 (41.9%) 0.001 
Fatigue 134 (23.4%) 45 (72.6%) 0.292 
Acute dehydration 0 (0%) 4 (6.5%) 0.121 
Pathological fractures 54 (9.5%) 8 (12.9%) 0.112 
Gastric and / or 
duodenal ulcer 
63 (11.1%) 6 (9.7%) 0.016 
Disturbance of 
consciousness or 
increased drowsiness 
0 (0%) 10 (16.2%) 0.001 
Depression 90 (15.9%) 0 (0%) 0 
Acute pancreatitis 45 (7.9%) 10 (16.1%) 0.001 
Coronary artery 
disease 
29 (5.1%) 13 (20.9%) 0.037 
No complaints 53 (9.4%) 0 (0%) 0 
 
 
Figure 1. Pre- and postoperative serum parathyroid hormone concentrations in a group of 
patients with threatening hypercalcaemic crisis 
 
 
Figure 2. Pre- and postoperative serum Ca2+ concentration in a group of patients with 
threatening hypercalcaemic crisis 
